ACR Meeting Abstracts

ACR Meeting Abstracts

Abstract Number: 457

Levels of Satisfaction with RA Treatment and Associated Alignment between Rheumatologists and Their Patients across Latin America

Enrique R Soriano1, José Antonio Maldonado-Cocco2, David Vega-Morales3, Diana Rocio Gil4, Ivanio Pereira5, Generoso Guerra6, Wilson Bautista-Molano7, Julio Casasola8, Valderilio F Azevedo9, Leandro Aldunate10 and Steve Lobosco11, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, CABA, Argentina, 2Buenos Aires University, Consulting Professor of Rheumatology, Buenos Aires University. Argentina, Buenos Aires, Argentina, 3Universidad Autónoma de Nuevo León. Rheumatology Service, Internal Medicine Department, Hospital Universitario "Dr. José Eleuterio González". Mexico, Monterrey, Mexico, 4ART Medica - Hospital Universitario Mayor MEDERI Internal Medicine and Rheumatology. Colombia., Bogota, Colombia, 5Rheumatology, Universidade Federal de Santa Catarina, Hospital Universitário, Divisão de Reumatologia.Brazil, Florianopolis, Brazil, 6Centro Médico Paitilla Internal Medicine and Rheumatology Department. Panama, Panama City, Panama, 7School of Medicine, Universidad Militar Nueva Granada and Rheumatology Department Hospital Militar. Colombia, Bogotá, Colombia, 8Rheumatology, Hospital General de Mexico, Mexico, Mexico, 9Adjunct Professor of Rheumatology, Federal University of Paraná; Brazil, Curitiba, Brazil, 10Immunology, Janssen Latin America, Buenos Aires, Argentina, 11Adelphi, Immunology Director- Adelphi Group, Manchester, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords:

Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess levels of rheumatologist and patient satisfaction with RA treatment across Latin America and any disconnects that may exist between the two in real world clinical practice.

Methods: Data from the 2015 RA Disease Specific Programme (DSP), a cross-sectional, multi-national survey of patients and rheumatologists conducted in Argentina, Mexico, Colombia and Venezuela were analyzed. Rheumatologists (n=141) completed forms containing patient demographics, patient disease severity and treatment satisfaction. Patients self-reported their level of treatment satisfaction and disease severity.

Results: A total of 555 RA patients from across Latin America were included in this analysis. Current mean age across Latin America was 51.9 years and 82.3% female. Proportions of rheumatologists and patients reporting satisfaction with treatment were statistically highly similar (79% and 83% respectively), however current disease severity reporting differed between rheumatologists and patients (mild 70% / moderate-severe 30% rheumatologists vs. 51% mild / 49% moderate-severe patients; p<0.001). When assessed for alignment, 21% of rheumatologists and patients disagreed on the level of satisfaction, driven mainly by rheumatologists over-stating dissatisfaction (13%) vs. their patient (8%) (p=0.031). For current disease severity, 36% of rheumatologists and patients disagreed, driven mainly by patients (28%) over-stating their severity vs. their rheumatologist (8%) (p<0.001). Of those patients for whom their rheumatologist was satisfied with treatment, 20% were classified as having moderate to severe RA by that same physician.

Conclusion: Despite many rheumatologists and their patients in Latin America reporting high levels of satisfaction with treatment, patients frequently remain moderate to severe and disconnected from their physician. There is a need to improve physician / patient engagement as a means to improving clinical control.

Disclosure: E. R. Soriano, AbbVie, Janssen, Novartis, Pfizer Inc, UCB, 2,AbbVie, Janssen, Novartis, Pfizer Inc, UCB, 5,AbbVie, Bristol-Myers Squibb, Janssen, Novartis, Pfizer Inc, Roche, UCB, 8; J. A. Maldonado-Cocco, None; D. Vega-Morales, None; D. Rocio Gil, None; I. Pereira, None; G. Guerra, None; W. Bautista-Molano, None; J. Casasola, None; V. F. Azevedo, AbbVie, Eli Lilly, Genentech, GSK, Pfizer Inc, UCB, 2,AbbVie, Merck-Serono, Novartis, Pfizer Inc, 5,AbbVie, Janssen, Merck-Serono, Novartis, Pfizer Inc, Sanofi, 8; L. Aldunate, Janssen Pharmaceutica Product, L.P., 3; S. Lobosco, Adelphi, 3.

To cite this abstract in AMA style:

Soriano ER, Maldonado-Cocco JA, Vega-Morales D, Rocio Gil D, Pereira I, Guerra G, Bautista-Molano W, Casasola J, Azevedo VF, Aldunate L, Lobosco S. Levels of Satisfaction with RA Treatment and Associated Alignment between Rheumatologists and Their Patients across Latin America [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/levels-of-satisfaction-with-ra-treatment-and-associated-alignment-between-rheumatologists-and-their-patients-across-latin-america/. Accessed .

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/levels-of-satisfaction-with-ra-treatment-and-associated-alignment-between-rheumatologists-and-their-patients-across-latin-america/